NCT03547973 2026-03-16
TROPHY U-01
Gilead Sciences
Phase 2 Recruiting
Clinical Trials
5 trialsNCT07232602 2026-03-16
MK-3475-04D
Merck Sharp & Dohme LLC
Phase 1/2 Recruiting
NCT07287995 2026-03-16
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Astellas Pharma Inc
Phase 1/2 Recruiting
NCT06862219 2026-03-06
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Astellas Pharma Inc
Phase 4 Recruiting
NCT06493552 2025-04-03
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
Vasgene Therapeutics, Inc
Phase 2/3 Recruiting